FindTrial
Sign In

Effficacy Evaluation and Prognostic Study of Severe Community-Acquired Pnuemonia: An Observational Study

Effficacy Evaluation and Prognostic Study of Severe Community-Acquired Pnuemonia: An Observational Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800019530
Enrollment
Unknown
Registered
2018-11-16
Start date
2017-07-15
Completion date
Unknown
Last updated
2018-11-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Severe Community-Acquired Pnuemonia

Interventions

Case series:Nil

Sponsors

Zhongshan Hospital, Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Conform to the diagnostic criteria of severe community-acquired pneumonia (2007 IDSA/ATS criteria); 2. aged at least 18 years old.

Exclusion criteria

Exclusion criteria: 1. Patients died within 24 hours since admission; 2. Patients with non-infectious pulmonary infiltration.

Design outcomes

Primary

MeasureTime frame
mortality;—

Countries

China

Contacts

Public ContactLei Zhu

Zhongshan Hospital, Fudan University

tfzhu@126.com+86 13916614876

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026